Hydrus® Trabecular Bypass Microstent With Phacoemulsification In Primary Angle Closure Glaucoma: 6 Months Of Efficacy And Safety.
Published 2024 - 42nd Congress of the ESCRS
Reference: PO1004 | Type: Free paper | DOI: 10.82333/xhha-8b15
Published 2024 - 42nd Congress of the ESCRS
Reference: PO1004 | Type: Free paper | DOI: 10.82333/xhha-8b15